OTC Markets OTCPK - Delayed Quote USD

Ventripoint Diagnostics Ltd. (VPTDF)

0.0886
-0.0014
(-1.56%)
At close: May 20 at 4:00:00 PM EDT
Loading Chart for VPTDF
  • Previous Close 0.0900
  • Open 0.0900
  • Bid 0.0825 x --
  • Ask 0.0940 x --
  • Day's Range 0.0900 - 0.0900
  • 52 Week Range 0.0497 - 0.2106
  • Volume 10,000
  • Avg. Volume 37,468
  • Market Cap (intraday) 14.312M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date May 28, 2025 - Jun 2, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.

ventripoint.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: VPTDF

View More

Performance Overview: VPTDF

Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

VPTDF
45.25%
S&P/TSX Composite index (^GSPTSE)
4.95%

1-Year Return

VPTDF
51.58%
S&P/TSX Composite index (^GSPTSE)
15.00%

3-Year Return

VPTDF
58.62%
S&P/TSX Composite index (^GSPTSE)
27.93%

5-Year Return

VPTDF
88,500.00%
S&P/TSX Composite index (^GSPTSE)
73.59%

Compare To: VPTDF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: VPTDF

View More

Valuation Measures

Annual
As of 5/20/2025
  • Market Cap

    14.31M

  • Enterprise Value

    15.44M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    205.63

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    226.45

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -236.18%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    95.17k

  • Net Income Avi to Common (ttm)

    -4.92M

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    60.55k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -2.4M

Research Analysis: VPTDF

View More

Company Insights: VPTDF

Research Reports: VPTDF

View More

People Also Watch